Delivery Order SPE2DR25D3201-SPE2DR26FT5AK
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,321.59 for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 18, 2025, with completion targeted for December 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under a larger contract vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $11,418.86 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,135.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a non-set-aside competitive award with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency has awarded a delivery order valued at $1,362.40 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitive, non-set-aside award utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $1,868.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam 10GM, a pharmaceutical product for medical supply. The contract was awarded on December 29, 2025, with an ultimate completion date of December 30, 2025, and carries no set-aside designation. Performance will occur at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,034.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside competitive award with a completion date of September 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam in a 10-gram quantity on December 3, 2025, with a ceiling value of $1,539.94. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,361.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of December 26, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5AKDelivery Order
The Defense Logistics Agency awarded a $1,014.70 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for Proctofoam-HC 1%-1% foam (10 grams), with an ultimate completion date of January 5, 2026. This competitive, non-set-aside contract features firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger federal contract vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement under AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense Logistics Agency. The company maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling such pharmaceutical and medical supply deliveries to support military healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurements across multiple therapeutic domains for Department of Defense and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/1/26 |